publication venue for
- A Functional Precision Oncology Approach to Identify Treatment Strategies for Myxofibrosarcoma Patients. 2021
- Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images. 2024
- Impact of rare and multiple concurrent gene fusions on diagnostic DNA methylation classifier in brain tumors. 2023
- Overlaid Transcriptional and Proteome Analyses Identify Mitotic Kinesins as Important Targets of Arylsulfonamide-Mediated RBM39 Degradation. 2023
- Overlaid transcriptome and proteome analyses identify mitotic kinesins as important targets of arylsulfonamide-mediated RBM39 degradation. 2023
- Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid Carcinoma. 2023
- The prostate stromal transcriptome in aggressive and lethal prostate cancer. 2022
- Transcriptomes of prostate cancer with TMPRSS2:ERG and other ETS fusions. 2022
- Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate Cancer. 2022
- Building tools for machine learning and artificial intelligence in cancer research: best practices and a case study with the PathML toolkit for computational pathology. 2021
- Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy.. 20. 2021
- Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistance.. 19. 2021
- p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities.. 19. 2021
- High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab.. 19. 2021
- Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer.. 19. 2021
- Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer.. 19. 2021
- Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor.. 19. 2021
- AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling.. 19. 2020
- Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum.. 19. 2020
- Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.. 18. 2020
- Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival.. 18. 2020
- Cdc42 Mediates Cancer Cell Chemotaxis in Perineural Invasion.. 18. 2020
- Combination Lenalidomide/Bortezomib Treatment Synergistically Induces Calpain-Dependent Ikaros Cleavage and Apoptosis in Myeloma Cells.. 18. 2020
- Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis.. 18. 2019
- Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.. 17. 2019
- MCL1 and DEDD Promote Urothelial Carcinoma Progression.. 17. 2019
- Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging.. 17. 2019
- Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.. 17. 2019
- Metabolic Detection of Bruton's Tyrosine Kinase Inhibition in Mantle Cell Lymphoma Cells. 17:1365-1377. 2019
- PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.. 17. 2018
- Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.. 17. 2018
- Impeding Circulating Tumor Cell Reseeding Decelerates Metastatic Progression and Potentiates Chemotherapy.. 16. 2018
- Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma.. 16. 2018
- Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.. 16. 2018
- Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes.. 16. 2018
- Targeted AKT Inhibition in Prostate Cancer Cells and Spheroids Reduces Aerobic Glycolysis and Generation of Hyperpolarized [1-13C] Lactate.. 16. 2018
- A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer.. 15. 2017
- Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation.. 15. 2017
- Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.. 15. 2017
- Metabolic Profiling in Formalin-Fixed and Paraffin-Embedded Prostate Cancer Tissues.. 15. 2017
- Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment.. 15. 2017
- Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment.. 14. 2016
- Identification of Targetable Kinase Alterations in Patients with Colorectal Carcinoma That are Preferentially Associated with Wild-Type RAS/RAF.. 14. 2015
- Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma.. 14. 2015
- Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model.. 14. 2015
- Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer.. 13. 2015
- The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression.. 13. 2015
- Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome.. 13. 2015
- AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.. 13. 2015
- The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.. 13. 2014
- p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints.. 13. 2014
- Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors.. 12. 2014
- Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.. 12. 2014
- Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors.. 12. 2013
- Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide.. 12. 2013
- The twist box domain is required for Twist1-induced prostate cancer metastasis.. 11. 2013
- Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor.. 11. 2013
- Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma.. 11. 2013
- Diminished origin-licensing capacity specifically sensitizes tumor cells to replication stress.. 11. 2013
- Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer.. 11. 2013
- Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.. 9. 2011
- Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib.. 8. 2010
- Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.. 7. 2009
- Rembrandt: helping personalized medicine become a reality through integrative translational research.. 7. 2009
- Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.. 6. 2008
- MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers.. 6. 2008
- Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas.. 6. 2008
- Acquisition of stable inducible up-regulation of nuclear factor-kappaB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells.. 6. 2008
- Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.. 6. 2008
- Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.. 5. 2007
- Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.. 4. 2006
- Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.. 4. 2006
- Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rate.. 3. 2005
- Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types.. 2. 2004
- Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.. 1. 2003
- Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.. 1. 2003
- Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.. 1. 2003
- Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.. 1. 2003
- Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.. 1. 2003
- Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes. 2018
- Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies. 2015
- The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential. 2014
- MDM2 and prognosis. 2004